Viewing Study NCT03923166


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2025-12-24 @ 4:19 PM
Study NCT ID: NCT03923166
Status: UNKNOWN
Last Update Posted: 2019-04-22
First Post: 2019-04-18
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-04-19
Start Date Type: ESTIMATED
Primary Completion Date: 2021-04-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2019-04-18
First Submit QC Date: None
Study First Post Date: 2019-04-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-04-19
Last Update Post Date: 2019-04-22
Last Update Post Date Type: ACTUAL